Description: Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, central lab, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; a testing laboratory for water, alcoholic, and non-alcoholic beverages; and clinical diagnostic services to patients, clinicians, hospitals, and central lab services to support clinical research studies. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, clinical diagnostics, electrical and electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, environment, health and safety, and packaging industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.
Home Page: vimta.com
Plot Nos. 141/2 & 142, IDA, Phase II
Hyderabad,
500051
India
Phone:
91 40 2726 4141
Officers
| Name | Title |
|---|---|
| Dr. Sivalinga Prasad Vasireddi | Executive Chairman |
| Ms. Harita Vasireddi | MD & Whole Time Director |
| Mr. D. R. Narahari Naidu | Chief Financial Officer |
| Mr. V. Hariman Vungal D.Tech | Executive Director of Operations & Executive Director |
| Ms. Sujani Vasireddi | Company Secretary & Compliance Officer |
| Mr. Satya Sreenivas Neerukonda | Executive Director |
| Mr. Suresh Kumar | President |
| Dr. Upendra Bhatnagar | Senior Vice President of Preclinical |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 34.6419 |
| Price-to-Book MRQ: | 6.0709 |
| Price-to-Sales TTM: | 6.431 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 1428 |